In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system mexA-mexB-OprM

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 287-291

  Ziha Zarifi, Isabelle ^a   Llanes, Catherine ^a   Köhler, Thilo ^b   Pechere, Jean Claude ^b   Plesiat, Patrick ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; QUINOLINE DERIVATIVE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CASE REPORT; GRAM NEGATIVE INFECTION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0033039934     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.287     Document Type: Article

References (40)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Balows, A., W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy. 1991. Manual of clinical microbiology, 5th ed. ASM Press, Washington, D.C.
3. Chen, H. Y., M. Yuan, and D. M. Livermore. 1995. Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J. Med. Microbiol. 43:300-309.
4. Figurski, D. H., and D. R. Helinski. 1979. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. USA 76:1648-1652.
5. Fish, D. N., S. C. Piscitelli, and L. H. Danziger. 1995. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 15:279-291.
6. Fukuda, H., M. Hosaka, S. Iyobe, N. Gotoh, T. Nishino, and K. Hirai. 1995. nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:790-792.
7. Godard, C., P. Plésiat, and Y. Michel-Briand. 1993. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months. Eur. J. Med. 2:117-120.
8. Gotoh, N., N. Itoh, H. Tsujimoto, J. Yamagishi, Y. Oyamada, and T. Nishino. 1994. Isolation of OprM-deficient mutants of Pseudomonas aeruginosa by transposon insertion mutagenesis: evidence of involvement in multiple antibiotic resistance. FEMS Microbiol. Lett. 122:267-273.
9. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
10. Jakics, E. B., S. Iyobe, K. Hirai, H. Fukuda, and H. Hashimoto. 1992. Occurrence of the nfxB type mutations in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:2562-2565.
11. Köhler, T. Unpublished data.
12. Köhler, T., M. Kok, M. Michéa Hamzehpour, P. Plésiat, N. Gotoh, T. Nishino, L. K. Curty, and J. C. Pechère. 1996. Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:2288-2290.
13. Köhler, T., M. Michéa Hamzehpour, U. Henze, N. Gotoh, L. Kocjancic Curty, and J. C. Pechère. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:345-354.
14. Köhler, T., M. Michéa Hamzehpour, P. Plésiat, A. L. Kahr, and J. C. Pechère. 1997. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2540-2543.
15. Li, X. Z., D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38:1732-1741.
16. Li, X. Z., D. Ma, D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob. Agents Chemother. 38:1742-1752.
17. Li, X. Z., H. Nikaido, and K. Poole. 1995. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1948-1953.
18. Li, X. Z., R. Srikumar, and K. Poole. 1998. β-Lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:399-403.
19. Livermore, D. M. 1984. Penicillin-binding proteins, porins and outer-membrane permeability of carbenicillin-resistant and -susceptible strains of Pseudomonas aeruginosa. J. Med. Microbiol. 18:261-270.
20. Masuda, N., and S. Ohya. 1992. Cross-resistance to meropenem. cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:1847-1851.
21. Masuda, N., E. Sakagawa, and S. Ohya. 1995. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:645-649.
22. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-175.
23. Michéa Hamzehpour, M., J. C. Pechère, P. Plésiat, and T. Köhler. 1995. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:2392-2396.
24. Morales, V. M., A. Bäckman, and M. Bagdasarian. 1991. A series of wide-host-range low-copy-number vectors that allow direct screening for recombinants. Gene 97:39-47.
25. Nikaido, H. 1996. Muitidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178:5853-5859.
26. Poole, K., K. Krebes, C. Mcnally, and S. Neshat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
27. Poole, K., K. Tetro, Q. X. Zhao, S. Neshat, D. E. Heinrichs, and N. Bianco. 1996. Expression of the muitidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother. 40:2021-2028.
28. Preheim, L. C., R. G. Penn, C. C. Sanders, R. V. Goering, and D. K. Giger. 1982. Emergence of resistance to β-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infection. Antimicrob. Agents Chemother. 22:1037-1041.
29. Rella, M., and D. Haas. 1982. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of β-lactam antibiotics: mapping of chromosomal genes. Antimicrob. Agents Chemother. 22:242-249.
30. Robillard, N. J. 1990. Broad-host-range gyrase A gene probe. Antimicrob. Agents Chemother. 34:1889-1894.
31. Robillard, N. J., and A. L. Scarpa. 1988. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO. Antimicrob. Agents Chemother. 32:535-539.
32. Sanders, C. C., and W. E. Sanders, Jr. 1983. Emergence of resistance during therapy with the newer β-lactam antibiotics: role of the inducible β-lactamases and implications for the future. Rev. Infect. Dis. 5:639-648.
33. Shannon, K., A. King, and I. Phillips. 1982. Development of resistance to beta-lactam antibiotics during therapy of Pseudomonas aeruginosa infections. Lancet i:1466.
34. Sirot, J., P. Courvalin, and C. J. Soussy. 1996. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria. Technical recommendations for in vitro susceptibility testing. Clin. Microbiol. Infect. 2:S5-S25.
35. Smith, A. W., and B. H. Iglewski. 1989. Transformation of Pseudomonas aeruginosa by electroporation. Nucleic Acids Res. 17:10509.
36. Sumita, Y., and M. Fukasawa. 1996. Meropenem resistance in Pseudomonas aeruginosa. Chemotherapy (Basel) 42:47-56.
37. Tenover, F. C., R. D, Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
38. Tsai, C. M., and C. E. Frash. 1982. A sensitive silver staining method for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119: 115-119.
39. Williams, R. J., D. M. Livermore, M. A. Lindridge, A. A. Said, and J. D. Williams. 1984. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa. J. Med. Microbiol. 17:283-293.
40. Yoshida, T., T. Muratani, S. Iyobe, and S. Mitsuhashi. 1994. Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 38:1466-1469.